Search research articles
Contact Us
Filters
Showing results (411-420 of 531) with videos related to
Page
of 54
Sort By:
Clinical Pharmacy
|
September 1, 1983
Evaluation of a method for intravenous phenytoin infusion
S C Boike, M J Rybak, J E Tintinalli, et al.
Antimicrobial Agents and Chemotherapy
|
June 4, 2014
Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus
Anthony M Casapao, Susan L Davis, John Paul McRoberts, et al.
Antimicrobial Agents and Chemotherapy
|
March 6, 2023
Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis<i>-oralis</i> Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance
Nagendra N Mishra, Wessam Abdelhady, Ahmed M Elsayed, et al.
Antibiotics (Basel, Switzerland)
|
January 22, 2024
Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in <i>Acinetobacter baumannii</i>
Jacinda C Abdul-Mutakabbir, Nana Sakyi Opoku, Karen K Tan, et al.
Pharmacotherapy
|
October 31, 2009
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
Michael J Rybak, Ben M Lomaestro, John C Rotschafer, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1991
Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis
M J Rybak, S A Lerner, D P Levine, et al.
The Journal of Antimicrobial Chemotherapy
|
September 28, 2018
Evaluation of dalbavancin alone and in combination with β-lactam antibiotics against resistant phenotypes of Staphylococcus aureus
Xhilda Xhemali, Jordan R Smith, Razieh Kebriaei, et al.
Antimicrobial Agents and Chemotherapy
|
September 20, 2017
A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity
Natalie A Finch, Evan J Zasowski, Kyle P Murray, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 3, 2009
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J Rybak, Ben M Lomaestro, John C Rotschafer, et al.
Antimicrobial Agents and Chemotherapy
|
July 20, 2016
Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model
Ashley D Hall Snyder, Brian J Werth, Poochit Nonejuie, et al.
Page
of 54
Search research articles
Search
Showing results (411-420 of 531) with videos related to
Sort By:
Page
of 54
Clinical Pharmacy
|
September 1, 1983
Evaluation of a method for intravenous phenytoin infusion
S C Boike, M J Rybak, J E Tintinalli, et al.
Antimicrobial Agents and Chemotherapy
|
June 4, 2014
Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus
Anthony M Casapao, Susan L Davis, John Paul McRoberts, et al.
Antimicrobial Agents and Chemotherapy
|
March 6, 2023
Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis<i>-oralis</i> Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance
Nagendra N Mishra, Wessam Abdelhady, Ahmed M Elsayed, et al.
Antibiotics (Basel, Switzerland)
|
January 22, 2024
Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in <i>Acinetobacter baumannii</i>
Jacinda C Abdul-Mutakabbir, Nana Sakyi Opoku, Karen K Tan, et al.
Pharmacotherapy
|
October 31, 2009
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
Michael J Rybak, Ben M Lomaestro, John C Rotschafer, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1991
Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis
M J Rybak, S A Lerner, D P Levine, et al.
The Journal of Antimicrobial Chemotherapy
|
September 28, 2018
Evaluation of dalbavancin alone and in combination with β-lactam antibiotics against resistant phenotypes of Staphylococcus aureus
Xhilda Xhemali, Jordan R Smith, Razieh Kebriaei, et al.
Antimicrobial Agents and Chemotherapy
|
September 20, 2017
A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity
Natalie A Finch, Evan J Zasowski, Kyle P Murray, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 3, 2009
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J Rybak, Ben M Lomaestro, John C Rotschafer, et al.
Antimicrobial Agents and Chemotherapy
|
July 20, 2016
Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model
Ashley D Hall Snyder, Brian J Werth, Poochit Nonejuie, et al.
Page
of 54